AdTAA/ecdCD40L-RGD

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAdTAA/ecdCD40L-RGD
Drug Alias Namerecombinant adenoviral vector vaccine (VectorLogics)AdFlu
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 modulators
TargetsTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVectorlogics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVectorlogics
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A